References
- Neal DE Jr, Clejan S Sarme D, Moon TD. Prostate specific antigen and prostatitis. I: Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate 1992;20: 105–11.
- Collazos J, Genollá J, Ruibal A. CA 15.3 in nonmalignant liver diseases. Int J Biol Markers 1991;6:188–92.
- Filella X, Cases A, Molina R, Jo J, Bedini JL, Revert L, Ballesta AM. Tumor markers in patients with chronic renal failure. Int J Biol Markers 1990;5:85–8.
- Fujita J, Ohtsuki Y, Bandoh S, Takashima H, Ueda Y, Wu F, Tojo Y, Kubo A, Ishida T. Elevation of cytokeratin 19 fragment (CYFRA 21-1) in serum of patients with radiation pneumonitis: possible marker of epithelial cell damage. Respir Med 2004;98:294–300.
- Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek, JW, Eggers P, Van Lente F, Greene T, Coresh J. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12.
- Filella X, Molina R, Jo J, Bedini JL, Joseph J, Ballesta AM. Tumor associated glycoprotein (TAG-72) levels in patients with non-malignant and malignant disease. Bull Cancer 1992;79:271–7.
- Filella X, Friese S, Roth HJ, Wehnl B. Technical performance of the Elecsys CA 72-4 test – development and field study. Anticancer Res 2000;20:5229–32.
- Collazos J, Genollà J, Ruibal A. Evaluation of the behavior of carcinoembryonic antigen in cirrhotic patients. Int J Biol Markers 1992;7:244–8.
- Trapé J, Filella X, Alsina-Donadeu M, Juan-Pereira L, Bosch-Ferrer Á, Rigo-Bonnin R; Oncology Section of the Catalan Association of Clinical Laboratory Science. Increased plasma concentrations of tumour markers in the absence of neoplasia. Clin Chem Lab Med. 2011;49: 1605–20.
- Balaban YH, Simsek H, Yilmaz R, Sarer-Yurekli BP, Shorbagi A, Tatar G. Tumor markers in familial Mediterranean fever and their correlation with the frequency of attacks. Clin Exp Rheumatol 2008;26:S114–6.